Lv3
270 积分 2024-02-04 加入
Targeting common EGFR mutations in NSCLC—review of global phase III trials of third-generation inhibitors
2个月前
已完结
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
2个月前
已完结
Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer
2个月前
已完结
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
2个月前
已完结
Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy?
3个月前
已完结
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer
4个月前
已完结
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer
4个月前
已完结
Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management
4个月前
已完结
Outcomes Following Localized Prostate Cancer Treatment
4个月前
已完结
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis
4个月前
已完结
皖公网安备34019202002308
